Pharmacelera raises €6.0M Series A round
18 February 2026· Barcelona, Spain· health, biotech, ai, b2b, pure_software
Pharmacelera will use the capital to establish a permanent team in Boston, Massachusetts, and expand its relationships with major pharmaceutical and biotech companies in the US, while also advancing its QaiM engine.
Investors
LeadHeran Partners
Also participating
InvereadyClave CapitalBio&Tech Smart Capital
About Pharmacelera
Stage
Series A
Headquarters
Barcelona, Spain
Founded
2015
Team Size
21–50
Sectors
healthbiotechaib2bpure_software